Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Hepatic steatosis is a major feature associated with NAFLD (non-alcoholic fatty liver disease). The aims of the present study were to assess the levels of PUFA (polyunsaturated fatty acids) in liver total lipids, triacylglycerols (triglycerides) and phospholipids of NAFLD patients in relation to those in adipose tissue and hepatic indexes related to oxidative stress as factors contributing to hepatic steatosis. Eleven control subjects and 19 patients with NAFLD were studied. Analysis of liver and abdominal adipose tissue fatty acids was carried out by GLC. The liver content of protein carbonyl groups and malondialdehyde were taken as indexes related to oxidative stress. NAFLD patients had a depletion in LCPUFA (long-chain PUFA) of the n-6 and n-3 series in liver triacylglycerols, with decreased 20:4,n-6/18:2,n-6 and (20:5,n-3+22:6,n-3)/18:3,n-3 ratios, whereas liver phospholipids contained higher n-6 and lower n-3 LCPUFA. These findings were accompanied by an enhancement of (i) n-6/n-3 ratio in liver and adipose tissue, (ii) 18:1,n-9 trans levels in adipose tissue, and (iii) hepatic lipid peroxidation and protein oxidation indexes. It is concluded that a marked enhancement in LCPUFA n-6/n-3 ratio occurs in the liver of NAFLD patients, a condition that may favour lipid synthesis over oxidation and secretion, thereby leading to steatosis. Depletion of hepatic LCPUFA may result from both defective desaturation of PUFA, due to inadequate intake of precursors, such as 18:3,n-3, and higher intake of the 18:1,n-9 trans isomer leading to desaturase inhibition, and from an increased peroxidation of LCPUFA due to oxidative stress.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The first lipidomic studies showed that individuals with moderate96 or severe97 obesity and MASLD had phospholipids rich in monounsaturated fatty acids (palmitoleic, oleic acid) and long-chain PUFAs (n-6:n-3 ratio, and n-6) compared with controls.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [97]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
Ohkawa, H., Ohishi, N., & Yagi, K. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90738-3 · Cited by 29,297
[38] Oxidative damage to proteins: Spectrophotometric method for carbonyl assay
Reznick, A. Z., & Packer, L. (1994) · Methods in Enzymology · doi:10.1016/s0076-6879(94)33041-7 · Cited by 2,452
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649
Biochemistry of Oxidative Stress
Sies, H. (1986) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198610581 · Cited by 1,306
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander-Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,144
Cytochrome P-4502E1: its physiological and pathological role
Lieber, C. S. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.2.517 · Cited by 889
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
Weltman, M. D., Farrell, G. C., Hall, P., Ingelman-Sundberg, M., & Liddle, C. (1998) · Hepatology · doi:10.1002/hep.510270121 · Cited by 614
Burdge, G. C., Jones, A. E., & Wootton, S. A. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2002662 · Cited by 598
Cited by
Items 201–300 of 703
Lifestyle Modification as the Primary Treatment of NASH
Neuschwander‐Tetri, B. A. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.006 · Cited by 66
Mi, Y., Tan, D., Yin, H., Zhou, X., Zhou, Q., & Ji, S. (2018) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-018-0859-0 · Cited by 62
Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms
Mandala, A., Janssen, R. C., Palle, S. K., Short, K. R., & Friedman, J. E. (2020) · Nutrients · doi:10.3390/nu12103166 · Cited by 66
Unbalanced oxidant–antioxidant status and its effects in pediatric diseases
Chiavaroli, V., Giannini, C., Marco, S. D., Chiarelli, F., & Mohn, A. (2011) · Redox Report · doi:10.1179/174329211x13049558293551 · Cited by 69
Fat Quality Influences the Obesogenic Effect of High Fat Diets
Crescenzo, R., Bianco, F., Mazzoli, A., Giacco, A., Cancelliere, R., Fabio, G. D., Zarrelli, A., Liverini, G., & Iossa, S. (2015) · Nutrients · doi:10.3390/nu7115480 · Cited by 64
Valenzuela, R., Rincón‐Cervera, M. Á., Echeverría, F., Barrera, C. R., Espinosa, A., Hernández‐Rodas, M. C., Ortíz, M., Valenzuela, A., & Videla, L. A. (2017) · Nutrition · doi:10.1016/j.nut.2017.07.007 · Cited by 62
Self-citationYeh, Y., Cho, Y.-Y., Hsieh, S., & Chiang, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-19553-1 · Cited by 61
In vivo triglyceride composition of abdominal adipose tissue measured by 1H MRS at 3T
Hamilton, G., Schlein, A. N., Middleton, M. S., Hooker, C. A., Wolfson, T. J., Gamst, A. C., Loomba, R. S., & Sirlin, C. B. (2016) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25453 · Cited by 58
Davinelli, S., Intrieri, M., Corbi, G., & Scapagnini, G. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1724871 · Cited by 59
Translational approaches: from fatty liver to non-alcoholic steatohepatitis.
Rosso, N., Chávez-Tapia, N. C., Tiribelli, C., & Bellentani, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i27.9038 · Cited by 65
Pérez‐Martínez, P., Pérez‐Jiménez, F., & López‐Miranda, J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.010 · Cited by 60
Shunmugaperumal, T. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.08.001 · Cited by 61
Fan, C., Ling-Hu, A., Sun, D., Gao, W., Zhang, C., Duan, X., Li, H., Tian, W., Yu, Q., & Ke, Z. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c06498 · Cited by 58
Moosavian, S. P., Arab, A., & Paknahad, Z. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.10.008 · Cited by 55
Quantitative 1H MRI and MRS of fatty acid composition
Peterson, P., Trinh, L., & Månsson, S. (2020) · Magnetic Resonance in Medicine · doi:10.1002/mrm.28471 · Cited by 55
Pediatric non-alcoholic fatty liver disease: New insights and future directions
Marzuillo, P., Giudice, E. M. D., & Santoro, N. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i4.217 · Cited by 60
Soto-Alarcón, S. A., Ortíz, M., Orellana, P., Echeverría, F., Bustamante, A., Espinosa, A., Illesca, P., Gonzalez‐Mañán, D., Valenzuela, R., & Videla, L. A. (2019) · BioFactors · doi:10.1002/biof.1556 · Cited by 55
Self-citationAdrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease
Nababan, S. H. H., Nishiumi, S., Kawano, Y., Kobayashi, T., Yoshida, M., & Azuma, T. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.04.009 · Cited by 53
Shin, S., & Ajuwon, K. M. (2018) · Nutrients · doi:10.3390/nu10020256 · Cited by 56
Balakrishnan, J., Kannan, S., & Govindasamy, A. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.12.003 · Cited by 56
Gormaz, J. G., Rodrigo, R., Videla, L. A., & Beems, M. V. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.05.003 · Cited by 57
Self-citationVuppalanchi, R., Cummings, O. W., Saxena, R., Ulbright, T. M., Martis, N., Jones, D. R., Bansal, N., & Chalasani, N. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225515.28536.3a · Cited by 51
Hwang, Y. P., Kim, H. G., Choi, J. H., Truong, M., Chung, Y., Jeong, T. C., & Jeong, H. G. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.12.006 · Cited by 57
Yahay, M., Heidari, Z., Allameh, Z., & Amani, R. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01433-9 · Cited by 48
Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice
Park, M.-Y., Kim, S. J., Ko, E., Ahn, S., Seo, H., & Sung, M. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13158 · Cited by 53
Tobin, D., Brevik-Andersen, M., Qin, Y., Innes, J. K., & Calder, P. C. (2018) · Nutrients · doi:10.3390/nu10081126 · Cited by 57
Drug discovery and treatment paradigms in nonalcoholic steatohepatitis
Noureddin, M., Muthiah, M. D., & Sanyal, A. J. (2020) · Endocrinology, Diabetes & Metabolism · doi:10.1002/edm2.105 · Cited by 52
Reversal of high-fat diet-induced hepatic steatosis by n-3 LCPUFA: Role of PPAR-α and SREBP-1c
Dossi, C. G., Tapia, G. S., Espinosa, A., Videla, L. A., & D'Espessailles, A. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.04.011 · Cited by 51
“One of the characteristics of NAFLD is the impaired bioavailability of liver n-6 and n-3 long-chain polyunsaturated fatty acids (LCPUFAs) [9].”
BackgroundSelf-citationFigueiredo, P. S., Inada, A. C., Fernandes, M. R., Arakaki, D. G., Freitas, K. D. C., Guimarães, R. D. C. A., do Nascimento, V. A., & Hiane, P. A. (2018) · Molecules · doi:10.3390/molecules23040877 · Cited by 52
A human liver chimeric mouse model for non-alcoholic fatty liver disease
Bissig-Choisat, B., Alves-Bezerra, M., Zorman, B., Ochsner, S. A., Barzi, M., Legras, X., Yang, D., Borowiak, M., Dean, A. M., York, R. B., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100281 · Cited by 49
Plant-Based Foods as a Source of Lipotropes for Human Nutrition: A Survey of In Vivo Studies
Fardet, A., & Chardigny, J. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2010.549596 · Cited by 52
Du, Z., Ma, T., Liaset, B., Keenan, A. H., Araujo, P. W., Lock, E., Demizieux, L., Degrace, P., Frøyland, L., Kristiansen, K., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.10.002 · Cited by 49
Non-Alcoholic Steatohepatitis: New Insights from OMICS Studies
Martel, C., Esposti, D. D., Bouchet, A., Brenner, C., & Lemoine, A. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112799857558 · Cited by 57
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
Scarpellini, E., Scarcella, M., Tack, J. F., Scarlata, G. G. M., Zanetti, M., & Abenavoli, L. (2024) · Antioxidants · doi:10.3390/antiox13111386 · Cited by 55
Cesaratto, L., Codarin, E., Vascotto, C., Leonardi, A., Kelley, M. R., Tiribelli, C., & Tell, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070909 · Cited by 53
Gündüz, F., Aboulnasr, F., Chandra, P. K., Hazari, S., Poat, B., Baker, D. P., Balart, L. A., & Dash, S. (2012) · Virology Journal · doi:10.1186/1743-422x-9-143 · Cited by 52
ELIZONDO, A., ARAYA, J., RODRIGO, R., SIGNORINI, C., SGHERRI, C., COMPORTI, M., PONIACHIK, J., & VIDELA, L. A. (2008) · Biological Research · doi:10.4067/s0716-97602008000100008 · Cited by 47
Self-citationMarsman, H. A., Heger, M., Kloek, J. J., Nienhuis, S., van Werven, J. R., Nederveen, A. J., ten Kate, F. J. W., Stoker, J., & van Gulik, T. M. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06326.x · Cited by 48
Review article: the management of paediatric nonalcoholic fatty liver disease
Mitchel, E. B., & Lavine, J. E. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12972 · Cited by 48
Tanner, N., Kubik, L., Luckert, C., Thomas, M., Hofmann, U., Zanger, U. M., Böhmert, L., Lampen, A., & Braeuning, A. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.078675 · Cited by 47
Parra‐Robert, M., Casals, E., Massana, N., Zeng, M., Perramón, M., Fernández‐Varo, G., Morales‐Ruiz, M., Puntes, V., Jiménez, W., & Casals, G. (2019) · Biomolecules · doi:10.3390/biom9090425 · Cited by 49
Lombardi, R., Iuculano, F., Pallini, G., Fargion, S. R., & Fracanzani, A. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228761 · Cited by 52
Hanke, D., Zahradka, P. C., Mohankumar, S. K., Clark, J. L., & Taylor, C. G. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.09.009 · Cited by 52
Park, H., Hasegawa, G., Shima, T., Fukui, M., Nakamura, N., Yamaguchi, K., Mitsuyoshi, H., Minami, M., Yasui, K., Itoh, Y., et al. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.012 · Cited by 50
Bouzianas, D. G., Bouziana, S. D., & Hatzitolios, A. I. (2013) · Nutrition Reviews · doi:10.1111/nure.12073 · Cited by 45
Valenzuela, R., Espinosa, A., Llanos, P., Hernández‐Rodas, M. C., Barrera, C. R., Vergara, D., Romero, N., Pérez, F., Manuel Ruz, O., & Videla, L. A. (2015) · Food & Function · doi:10.1039/c5fo01086a · Cited by 45
Self-citationMarsman, H. A., Heger, M., Kloek, J. J., Nienhuis, S., ten Kate, F. J. W., & van Gulik, T. M. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.07.009 · Cited by 45
Free fatty acids sensitize hepatocytes to bile acid-induced apoptosis
Pusl, T., Wild, N., Vennegeerts, T., Wimmer, R., Göke, B., Brand, S., & Rust, C. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.113 · Cited by 48
Park, S., Lee, J., Lee, J., Lee, J. K., Byun, J., Kim, I., & Ha, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126384 · Cited by 47
Towards a whole-body systems [multi-organ] lipidomics in Alzheimer’s disease
Astarita, G., & Piomelli, D. (2011) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1016/j.plefa.2011.04.021 · Cited by 44
Musazadeh, V., Karimi, A., Malekahmadi, M., Ahrabi, S. S., & Dehghan, P. (2023) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13750 · Cited by 44
Impaired Microsomal Oxidation of the Atypical Antipsychotic Agent Clozapine in Hepatic Steatosis
Zhang, W. V., Ramzan, I. M., & Murray, M. T. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.124024 · Cited by 46
Mcl-1 Degradation during Hepatocyte Lipoapoptosis
Masuoka, H. C., Mott, J., Bronk, S. F., Werneburg, N. W., Akazawa, Y., Kaufmann, S. H., & Gores, G. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.039545 · Cited by 42
Ultrasonography to Quantify Hepatic Fat Content: Validation by 1H Magnetic Resonance Spectroscopy
Edens, M. A., van Ooijen, P. M. A., Post, W. J., Haagmans, M., Kristanto, W., Sijens, P. E., van der Jagt, E. J., & Stolk, R. P. (2009) · Obesity · doi:10.1038/oby.2009.154 · Cited by 48
Kadegowda, A. K. G., Connor, E. E., Teter, B. B., Sampugna, J., Delmonte, P., Piperova, L. S., & Erdman, R. A. (2010) · Journal of Nutrition · doi:10.3945/jn.109.110890 · Cited by 43
A novel AMPK activator, WS070117, improves lipid metabolism discords in hamsters and HepG2 cells
Lian, Z., Li, Y., Gao, J. H., Qu, K., Li, J., Hao, L.-H., Wu, S., & Zhu, H. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-67 · Cited by 45
Jauregibeitia, I., Portune, K. J., Rica, I., Tueros, I., Velasco, O., Grau, G., Trebolazabala, N., Castaño, L. A., Larocca, A. V., Ferreri, C., et al. (2020) · Nutrients · doi:10.3390/nu12113446 · Cited by 44
Musazadeh, V., Dehghan, P., Saleh‐Ghadimi, S., & Farhangi, M. A. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14744 · Cited by 45
Kuś, E., Zabielski, P., Kochan, K., Kuś, K., Jasztal, A., Sitek, B., Proniewski, B., Wójcik, T., Gula, K., Kij, A., et al. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.12.004 · Cited by 44
Treatment of Non-Alcoholic Fatty Liver Disease
Dyson, J. K., & Day, C. (2014) · Digestive Diseases · doi:10.1159/000360511 · Cited by 54
Dağıstanlı, F. K., Tanrıverdi, G., Altınok, A., Özyazgan, S., & Öztürk, M. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.11.026 · Cited by 44
Um, M. Y., Moon, M. K., Ahn, J., & Ha, T. Y. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114512005260 · Cited by 43
Anti-lipoapoptotic effect of Artemisia capillaris extract on free fatty acids-induced HepG2 cells
Jang, E., Shin, M.-H., Kim, K., Kim, Y., Na, Y., Woo, H.-J., Kim, Y., Lee, J. H., & Jang, H.-J. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-253 · Cited by 44
Huang, W., Wang, G., Xia, Y., Xiong, Z., & Ai, L. (2020) · Food & Nutrition Research · doi:10.29219/fnr.v64.3751 · Cited by 44
Non-alcoholic fatty liver disease and lipotoxicity
Wasilewska, N., & Lebensztejn, D. M. (2021) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2021.104441 · Cited by 46
Wu, H., Chen, W., Cheng, K., Ku, P., Yeh, C., & Cheng, J. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.07.006 · Cited by 49
Impact of dietary n-6/n-3 fatty acid ratio of atherosclerosis risk: A review
Cao, M., Yang, F., McClements, D. J., Guo, Y., Liu, R., Chang, M., Wei, W., Jin, J., & Wang, X. (2024) · Progress in Lipid Research · doi:10.1016/j.plipres.2024.101289 · Cited by 46
Sungurtekin, H., Değirmenci, S., Sungurtekin, U., Oguz, B. E., Sabir, N., & Kaptanoglu, B. (2011) · Nutrition in Clinical Practice · doi:10.1177/0884533611418783 · Cited by 41
Calder, P. C. (2017) · Nutrition Bulletin · doi:10.1111/nbu.12261 · Cited by 39
An, W., He, H., Dong, X., Tan, B., Yang, Q., Chi, S., Zhang, S., Liu, H., & Yang, Y. (2020) · Aquaculture Reports · doi:10.1016/j.aqrep.2020.100321 · Cited by 44
DHA supplementation prevent the progression of NASH via GPR120 signaling
Nakamoto, K., Shimada, K., Harada, S., Morimoto, Y. M., Hirasawa, A., & Tokuyama, S. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.11.046 · Cited by 41
Hofacer, R. D., Jandacek, R. J., Rider, T., Tso, P., Magrisso, I. J., Benoit, S. C., & McNamara, R. K. (2011) · Nutrition Research · doi:10.1016/j.nutres.2011.08.007 · Cited by 41
Dietary approach in the treatment of nonalcoholic fatty liver disease
Ferolla, S. M., Silva, L. C., Ferrari, M. D. L. A., da Cunha, A. S., Martins, F. D. S., Couto, C. A., & Ferrari, T. C. A. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i24.2522 · Cited by 41
Soni, N. K., Nookaew, I., Sandberg, A., & Gabrielsson, B. G. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0072-8 · Cited by 38
Wang, B., Fu, J., Li, L., Gong, D., Wen, X., Yu, P., & Zeng, Z. (2016) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2016.1153611 · Cited by 41
Osman, R. H., Liu, L., Xia, L., Zhao, X., Wang, Q., Sun, X., Zhang, Y., Yang, B., Zheng, Y., Gong, D., et al. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2737-7 · Cited by 38
Non-Alcoholic Fatty Liver Disease, an Overview.
Muhammad, A. (2019) · PubMed Central · Cited by 51
Yang, Y., Du, L., Hosokawa, M., & Miyashita, K. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103741 · Cited by 38
Gai, H., Zhou, F. J., Zhang, Y., Ai, J., Zhan, J., You, Y., & Huang, W. (2020) · Journal of Food Science · doi:10.1111/1750-3841.15482 · Cited by 38
Estimation of Fish and ω‐3 Fatty Acid Intake in Pediatric Nonalcoholic Fatty Liver Disease
St‐Jules, D. E., Watters, C. A., Brunt, E. M., Wilkens, L. R., Novotny, R., Belt, P. H., & Lavine, J. E. (2013) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3182a1df77 · Cited by 43
Dietary walnut oil modulates liver steatosis in the obese Zucker rat
Fink, A., Rüfer, C. E., Grandois, J. L., Röth, A., Werner, D., Marchioni, E., Bub, A., & Barth, S. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0573-z · Cited by 42
Coenen, K. R., & Hasty, A. H. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00171.2007 · Cited by 38
Delarue, J., & Lallès, J. P. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500346 · Cited by 40
Kamath, S., Chávez, A. O., Gastaldelli, A., Casiraghi, F., Halff, G. A., ABRAHAMIAN, G. A., Davalli, A. M., Bastarrachea, R. A., Comuzzie, A. G., Guardado‐Mendoza, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027617 · Cited by 40
Multidisciplinary Pharmacotherapeutic Options for Nonalcoholic Fatty Liver Disease
Nakajima, K. (2012) · International Journal of Hepatology · doi:10.1155/2012/950693 · Cited by 45
Ding, Y., Gu, Z., Wang, Y., Wang, S., Chen, H., Zhang, H., Chen, W., & Chen, Y. Q. (2017) · Food & Function · doi:10.1039/c7fo00096k · Cited by 42
Pathogenesis of and major animal models used for nonalcoholic fatty liver disease
Jiang, M., Wu, N., Chen, X., Wang, W., Chu, Y., Liu, H., Li, W., Chen, D., Li, X., & Xu, B. (2019) · Journal of International Medical Research · doi:10.1177/0300060519833527 · Cited by 40
Jiao, J., & Zhang, Y. (2013) · Chemical Reviews · doi:10.1021/cr300007p · Cited by 37
n−3 Fatty acids ameliorate hepatic steatosis and dysfunction after LXR agonist ingestion in mice
Jung, U. J., Millman, P. N., Tall, A. R., & Deckelbaum, R. J. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.06.003 · Cited by 36
Sophocarpine alleviates hepatocyte steatosis through activating AMPK signaling pathway
Song, C., Shi, J. G., Zeng, X. Y., Zhang, Y., Xie, W., & Chen, Y.-X. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.01.020 · Cited by 36
Grasselli, E., Canesi, L., Portincasa, P., Voci, A., Vergani, L., & Demori, I. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.2713 · Cited by 35
Torquato, P., Bartolini, D., Giusepponi, D., Piroddi, M., Sebastiani, B., Saluti, G., Galarini, R., & Galli, F. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.11.036 · Cited by 35
Ghazali, R. F., Mehta, K. J., Bligh, S. W. A., Tewfik, I., Clemens, D. L., & Patel, V. B. (2020) · World Journal of Hepatology · doi:10.4254/wjh.v12.i3.84 · Cited by 36
Lu, Z., Wang, J., Li, M., Liu, Q., Wei, D., Yang, M., & Kong, L. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.09.006 · Cited by 37
Mashtoub, S., Tran, C. D., & Howarth, G. S. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/429706 · Cited by 35
TINIAKOS, D. G., Anstee, Q. M., & Burt, A. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00005-4 · Cited by 37
Choi, Y., Abdelmegeed, M. A., & Song, B. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.08.013 · Cited by 36
Arachidonic acid impairs hypothalamic leptin signaling and hepatic energy homeostasis in mice
Cheng, L., Yu, Y., Zhang, Q., Szabo, A., Wang, H., & Huang, X. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.04.025 · Cited by 37
Zhao, Y., Yang, G., Wu, N., Cao, X., & Gao, J. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.103967 · Cited by 47
Castañé, H., Baiges‐Gayà, G., Hernández‐Aguilera, A., Rodríguez‐Tomàs, E., Fernández‐Arroyo, S., Herrero, P., Delpino-Rius, A., Canela-Canela, N., Menéndez, J. A., Camps, J., et al. (2021) · Biomolecules · doi:10.3390/biom11030473 · Cited by 36
Metadata
- Authors
- ARAYA, J., RODRIGO, R., VIDELA, L. A., THIELEMANN, L., ORELLANA, M., PETTINELLI, P., & PONIACHIK, J.
- Affiliations
- Departamento de Nutrición, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Casilla 70058, Santiago 7, Santiago, Chile
- University of Chile (CL)
- Programa de Farmacología Molecular y Clínica, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Casilla 70058, Santiago 7, Santiago, Chile
- Servicio de Gastroenterología, Hospital Clínico de la Universidad de Chile, Casilla 70058, Santiago 7, Santiago, Chile
- Corresponding author
- PETTINELLI, Paulina
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2004-06-01
- Volume
- 106
- Issue
- 6
- Pages
- 635-643
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2072721395
- Cited by
- 700
- References
- 46
- Citations by year
- 2026: 12 · 2025: 27 · 2024: 25 · 2023: 26 · 2022: 31 · 2021: 42 · 2020: 56 · 2019: 43 · 2018: 34 · 2017: 46 · 2016: 41 · 2015: 41 · 2014: 39 · 2013: 37 · 2012: 40
- FWCI
- 12.00
- Type
- journal article
- Language
- en
- Open access
- green
- americanae.aecid.es
- Licence
- other-oa
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Universidad de Chile (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- non-alcoholic fatty liver disease, hepatic steatosis, long-chain polyunsaturated fatty acids, n-6/n-3 ratio, hepatic triglycerides, hepatic phospholipids, adipose tissue fatty acids, trans fatty acids, lipid peroxidation, oxidative stress, protein carbonylation, malondialdehyde, fatty acid desaturation
- MeSH terms
- Adipose Tissue, Adult, Fatty Acids, Unsaturated, Fatty Liver, Humans, Lipids, Liver, Middle Aged, Phospholipids, Triglycerides, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.